학술논문

Upper Tract Urinary Carcinoma: A Unique Immuno-Molecular Entity and a Clinical Challenge in the Current Therapeutic Scenario.
Document Type
Article
Source
Technology in Cancer Research & Treatment; 2/28/2023, p1-17, 17p
Subject
URINARY organs
FIBROBLAST growth factor receptors
ANTIBODY-drug conjugates
TRANSITIONAL cell carcinoma
COMBINATION drug therapy
Language
ISSN
15330346
Abstract
Copyright of Technology in Cancer Research & Treatment is the property of Sage Publications Inc. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)